|
VKC
MCID: VRN004
|
Vernal Keratoconjunctivitis malady |
|
Sources: 30NIH Rare Diseases, 44Wikipedia, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Vernal keratoconjunctivitis (VKC) is a chronic, severe allergy that affects the surfaces of the eyes. It most commonly occurs in boys living in warm, dry climates. Attacks associated with VKC are common in the spring (hence the name "vernal") and summer but often reoccur in the winter. Signs and symptoms usually begin before 10 years of age and may include hard, cobblestone-like bumps (papillae) on the upper eyelid; sensitivity to light; redness; sticky mucus discharge; and involuntary blinking or spasms of the eyelid (blepharospasm). The condition usually subsides at the onset of puberty. It is caused by a hypersensitivity (allergic reaction) to airborne-allergens. Management focuses on preventing "flare ups" and relieving the symptoms of the condition.30
MalaCards: Vernal Keratoconjunctivitis, also known as keratoconjunctivitis, vernal, is related to superior limbic keratoconjunctivitis and papillary conjunctivitis. An important gene associated with Vernal Keratoconjunctivitis is CCL24 (chemokine (C-C motif) ligand 24), and among its related pathways are Immune response Oncostatin M signaling via JAK-Stat in human cells and Class A/1 (Rhodopsin-like receptors). The drugs lodoxamide tromethamine and lodoxamide and the compounds budesonide and glycosaminoglycan have been mentioned in the context of this disorder. Affiliated tissues include t cells and b cells, and related mouse phenotypes are respiratory system and immune system. Wikipedia: Vernal keratoconjunctivitis (VKC) or Spring catarrh is a recurrent, bilateral, and self-limiting...44 more... |
|
Sources: 43UMLS, 30NIH Rare Diseases, 32Novoseek See all sources |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for vernal keratoconjunctivitis Drug clinical trials:Search ClinicalTrials for vernal keratoconjunctivitis Search NIH Clinical Center for vernal keratoconjunctivitis Search CenterWatch for vernal keratoconjunctivitis Inferred drug relations via UMLS/NDF-RT:43 28 lodoxamide, lodoxamide tromethamine |
|
|
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to vernal keratoconjunctivitis:22T cells, B cells
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to vernal keratoconjunctivitis:25 (show all 12)
|
|
Sources: 35PubMed See all sources |
Articles related to vernal keratoconjunctivitis:(show all 38)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 10EMD Millipore, 38Reactome, 36QIAGEN, 41Thomson Reuters, 20KEGG, 3Cell Signaling Technology, 37R&D Systems See all sources |
Pathways related to vernal keratoconjunctivitis according to GeneDecks:(show top 50) (show all 101)
|
|
Sources: 32Novoseek , 42Tocris Bioscience, 9DrugBank, 18HMDB, 34PharmGKB See all sources |
Compounds related to vernal keratoconjunctivitis according to GeneDecks:(show top 50) (show all 291)
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to vernal keratoconjunctivitis according to GeneDecks:
Biological processes related to vernal keratoconjunctivitis according to GeneDecks:(show all 39)
Molecular functions related to vernal keratoconjunctivitis according to GeneDecks:(show all 8)
|
